← FDA Drug Approvals (Drugs@FDA)

MARGENZA

BLA · Biologics License Application · Sponsor: MACROGENICS INC · Approved 2020-12-16

Drug application

FDA Application #
BLA761150
Application type
Biologics License Application
Brand name
MARGENZA
Generic name
MARGETUXIMAB-CMKB
Active ingredients
MARGETUXIMAB-CMKB
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
MACROGENICS INC
Manufacturer
TerSera Therapeutics LLC
First approval
2020-12-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown